Aiwu Ruth He, MD, PhD, Discusses 3-Year Survival Data for Durvalumab Plus Chemo in Biliary Tract Cancer, Other Advances
This interview will appear in the June issue of Evidence-Based Oncology.
Source: ajmc.com
Stay updated with breaking news from Durable After. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This interview will appear in the June issue of Evidence-Based Oncology.